- $1.16bn
- $1.13bn
- CNY117.43m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 122 | 180 | 56.8 | 44.3 | 117 |
Cost of Revenue | |||||
Gross Profit | 71.2 | 106 | 36 | 29.2 | 75.3 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 168 | 271 | 377 | 348 | 414 |
Operating Profit | -46.3 | -91.3 | -321 | -304 | -296 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -47.2 | -92.1 | -313 | -329 | -301 |
Provision for Income Taxes | |||||
Net Income After Taxes | -47.9 | -92.3 | -314 | -330 | -301 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -48.5 | -87.6 | -314 | -328 | -302 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -75.8 | -87.6 | -314 | -328 | -302 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.692 | -0.8 | -2.77 | -2.86 | -2.48 |